These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14525785)

  • 21. Donor and recipient pretransplant conditioning with nonlethal radiation and antilymphocyte serum improves the graft survival in a rat small bowel transplant model.
    Bakonyi A; Berho M; Ruiz P; Misiakos EP; Carreno M; de Faria W; Sommariva A; Inverardi L; Miller J; Ricordi C; Tzakis AG
    Transplantation; 2001 Sep; 72(6):983-8. PubMed ID: 11579288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stem cell transplantation in primary immunodeficiency disease patients.
    Sato T; Kobayashi R; Toita N; Kaneda M; Hatano N; Iguchi A; Kawamura N; Ariga T
    Pediatr Int; 2007 Dec; 49(6):795-800. PubMed ID: 18045274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of immune reconstitution in children undergoing cord blood transplantation.
    Moretta A; Maccario R; Fagioli F; Giraldi E; Busca A; Montagna D; Miniero R; Comoli P; Giorgiani G; Zecca M; Pagani S; Locatelli F
    Exp Hematol; 2001 Mar; 29(3):371-9. PubMed ID: 11274766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of donor-recipient strain combination on rejection and graft-versus-host disease after small bowel/liver transplantation in the rat.
    Zhong R; He G; Sakai Y; Zhang Z; Garcia B; Li XC; Jevnikar A; Grant D
    Transplantation; 1993 Aug; 56(2):381-5. PubMed ID: 8356594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both.
    Murase N; Ye Q; Nalesnik MA; Demetris AJ; Abu-Elmagd K; Reyes J; Ichikawa N; Okuda T; Fung JJ; Starzl TE
    Transplantation; 2000 Dec; 70(11):1632-41. PubMed ID: 11152226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
    Al-Mousa H; Al-Shammari Z; Al-Ghonaium A; Al-Dhekri H; Al-Muhsen S; Al-Saud B; Arnaout R; Al-Seraihy A; Al-Jefri A; Al-Ahmari A; Ayas M; El-Solh H
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):818-23. PubMed ID: 20079864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-Center Experience of Unrelated and Haploidentical Stem Cell Transplantation with TCRαβ and CD19 Depletion in Children with Primary Immunodeficiency Syndromes.
    Balashov D; Shcherbina A; Maschan M; Trakhtman P; Skvortsova Y; Shelikhova L; Laberko A; Livshits A; Novichkova G; Maschan A
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1955-62. PubMed ID: 26187864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Phenotype and Treatment of WIP Deficiency: Literature Synopsis and Review of a Patient With Pre-transplant Serial Donor Lymphocyte Infusions to Eliminate CMV.
    Schwinger W; Urban C; Ulreich R; Sperl D; Karastaneva A; Strenger V; Lackner H; Boztug K; Albert MH; Benesch M; Seidel MG
    Front Immunol; 2018; 9():2554. PubMed ID: 30450104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of innate and acquired immune mechanisms in clinical intestinal transplant rejection.
    Mathew JM; Tryphonopoulos P; DeFaria W; Ruiz P; Miller J; Barrett TA; Tzakis AG; Kato T
    Transplantation; 2015 Jun; 99(6):1273-81. PubMed ID: 25539468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term immune reconstitution after anti-CD52-treated or anti-CD34-treated hematopoietic stem cell transplantation for severe T-lymphocyte immunodeficiency.
    Slatter MA; Brigham K; Dickinson AM; Harvey HL; Barge D; Jackson A; Bown N; Flood TJ; Cant AJ; Abinun M; Gennery AR
    J Allergy Clin Immunol; 2008 Feb; 121(2):361-7. PubMed ID: 18086494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apoptosis of T lymphocytes in liver and/or small bowel allografts during tolerance induction.
    Meyer D; Baumgardt S; Loeffeler S; Czub S; Otto C; Gassel HJ; Timmermann W; Thiede A; Ulrichs K
    Transplantation; 1998 Dec; 66(11):1530-6. PubMed ID: 9869096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-CD4 therapy in combined heart-kidney, heart-liver, and heart-small bowel allotransplants in high-responder rats.
    Yin DP; Sankary HN; Talor-Edwards C; Chong AS; Foster P; Shen J; Ma LL; Williams JW; Fathman CG
    Transplantation; 1998 Jul; 66(1):1-5. PubMed ID: 9679814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of CMV and EBV on Immune Recovery After Allogeneic Hematopoietic Cell Transplantation in Children.
    Pukownik E; Kubicka M; Kurylo-Rafinska B; Debski R; Galazka P; Czyzewski K; Krenska A; Bartoszewicz N; Demidowicz E; Marjańska A; Dziedzic M; Pogorzala M; Wysocki M; Styczynski J
    Anticancer Res; 2018 Oct; 38(10):6009-6013. PubMed ID: 30275233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
    Sakagawa T; Kiyochi H; Honda K; Kobayashi N
    Transpl Immunol; 2004 Nov; 13(3):161-8. PubMed ID: 15381198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation.
    Minculescu L; Marquart HV; Ryder LP; Andersen NS; Schjoedt I; Friis LS; Kornblit BT; Petersen SL; Haastrup E; Fischer-Nielsen A; Reekie J; Sengelov H
    Front Immunol; 2019; 10():1997. PubMed ID: 31507601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful immune reconstitution in severe combined immunodeficiency despite Epstein-Barr virus and cytomegalovirus infections.
    DeVoe PW; Buckley RH; Shirley LR; Darby CP; Ward FE; Mickey GH; Raab-Traub N; Vandenbark GR
    Clin Immunol Immunopathol; 1985 Jan; 34(1):48-59. PubMed ID: 2981167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lessons learned in pediatric small bowel and liver transplantation from living-related donors.
    Gangemi A; Tzvetanov IG; Beatty E; Oberholzer J; Testa G; Sankary HN; Kaplan B; Benedetti E
    Transplantation; 2009 Apr; 87(7):1027-30. PubMed ID: 19352122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined liver/small bowel transplantation using a blood group compatible but nonidentical donor.
    Sindhi R; Landmark J; Shaw BW; Fox IJ; Heffron TG; Vanderhoof J; Langnas AN
    Transplantation; 1996 Jun; 61(12):1782-3. PubMed ID: 8685962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment with either anti-CD4 or anti-CD8 monoclonal antibodies blocks alphabeta T cell-mediated rejection of intestinal allografts in mice.
    Newell KA; He G; Hart J; Thistlethwaite JR
    Transplantation; 1997 Oct; 64(7):959-65. PubMed ID: 9381541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hereditary multiple intestinal atresias: 2 new cases and review of the literature.
    Cole C; Freitas A; Clifton MS; Durham MM
    J Pediatr Surg; 2010 Apr; 45(4):E21-4. PubMed ID: 20385266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.